OSL oncosil medical ltd

Ann: OncoSil Appoints Rachel Duggan as EMEA Sales Director, page-8

  1. 1,598 Posts.
    lightbulb Created with Sketch. 215
    The only reason, the market did not respond to the GBA, is because they did not have a chance. It is also important to not that as soon as the tripp and panco trials are over, spending will decline.
    As for the FDA, again, waiting for these trials to finish. An amendment to 10 CFR 35.1000, changes things. Which is why FDA will be much later.
    HODL
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.16
Change
-0.010(0.86%)
Mkt cap ! $21.74M
Open High Low Value Volume
$1.17 $1.17 $1.14 $80.47K 69.48K

Buyers (Bids)

No. Vol. Price($)
1 2150 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 7380 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.